(Corrects paragraph 8 to clarify the potential impact of AbbVie's lawsuit.) April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible ...
The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...
President Donald Trump has repeatedly vowed to “cut waste, fraud and abuse everywhere that we can find it.” Congressional ...
Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access ...
The 340B drug discount program would work better if the money followed the patient rather than going directly to hospitals, Anthony DiGiorgio, DO, MHA, said Monday at an event on 340B sponsored by the ...
Mere days before the Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program’s (“Pilot”) scheduled January 1, 2026 effective date, a federal district court granted a ...
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain financial stability. A hospital’s DSH percentage is critical ...
Hospitals are not as unpopular as other health care sectors, such as drug manufacturers and insurance companies. But like other ...
Hospitals are not as unpopular as other health care sectors, such as drug manufacturers and insurance companies. But like other businesses, they are prone to rent-seeking and fiercely defensive of ...
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results